1[1]The DCCT Research group. Factors in the developments of diabetic nearopathy in the feasibility phase of the diabetes control and complica tions Trial(DCCT). Diabetes, 1998,47: 476 481
2[2]Norman EC,Mary AC. Metabolic and Vascular Factors in the pathogenesis of diabetic neuropathy. Diabetes, 1997,46[Suppl 2]: S3 1 -S37
4[4]Ford I,Malik RA.Newrick PG.et al. Relationship between haemostatic factors and capillary morphology in human diabetic neuropathy. Thrombosis and Haemostasis, 1992 , 68 ( 6 ): 628 633
5[5]Ward JD,Tesfaye S. Pathogenesis of human diabetic neuropathy. In the textbook of diabetes. Vol 2, Pickup J, Williams G, Eds. Oxford, Blackwe11Sci,1997,49:1-19
6[6]Paisey R,Harkness J,Hartog M,et al. The effect of improvement in diabetic control on plasma and whole blood viscosity Diabetologia, 1980,18:345-349
7[7]Srivastava A, Joshi CS, Sethi PPS, et al. Alfered platelet function in non insulindependent diabetes mellitus. Thuromb Res, 1994,76 ( 5 ):451-461
8[8]Malik RA. The pathology of human diabetic neuropathy. Diabetes,1997,46[Suppl 2]:S50 S53
